Rifabutin
Rifabutin (formerly ansamycin; Mycobutin - Adria), a rifamycin antibiotic similar to rifampin (Rifadin, Rimactane) was recently approved by the US Food and Drug Administration for prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Rifabutin
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 895
Article Code: 895b
Date: April 30, 1993
Volume: 35
Pages: 36-38
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 895
Article Code: 895b
Date: April 30, 1993
Volume: 35
Pages: 36-38
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)